Novel fluorinated thiazolidin-4-one derivatives: synthesis and anti-cancer potential against HepG2 and HCT116 cell lines
Shreyash D. Kadam A , Denni Mammen
A * , Vishwanath Zunjar A and Rahul R. Bagul B
A
B
Abstract
A novel synthetic route has been designed to introduce fluorine functionality into a series of compounds containing thiazolidin-4-one rings. These compounds were synthesised from various aniline derivatives using a two-step approach: an addition reaction of ethyl isothiocyanate with different aromatic fluorinated anilines, followed by cyclisation to yield the final products. A total of 15 novel fluorinated thiazolidinone compounds were synthesised and characterised using 1H NMR, 19F NMR, Fourier transform–infrared, elemental analysis and liquid chromatography–mass spectrometry. Stereochemistry around the imine bond in the synthesised derivatives was determined using nuclear Overhauser effect spectroscopy. The in vitro anticancer potential of the compounds was tested against two human cancer cell lines, liver (HepG2) and colon (HCT116). The study revealed that the derivatives having fluorine functionality at both the m-positions in the aromatic ring showed promising anticancer potential, as compared to those at o- and p-positions.
Keywords: aniline derivatives, anticancer, EC50, fluorine, HCT116 cell line, HepG2 cell line, iminothiazolidinone, synthesis.
References
1 Appalanaidu K, Dadmal T, Jagadeesh Babu N, Kumbhare RM. An improved one-pot multicomponent strategy for the preparation of thiazoline, thiazolidinone and thiazolidinol scaffolds. RSC Adv 2015; 5(107): 88063-9.
| Crossref | Google Scholar |
2 Narges RB, Shariati N. Solvent-free synthesis of novel benzothiazole-substituted 4-thiazolidinones using nano silica-bonded 5-n-propyl-octahydro-pyrimido[1,2-a]azepinium chloride as catalyst. Aust J Chem 2014; 67: 1646-55.
| Crossref | Google Scholar |
3 Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK. 4-Thiazolidinones: the advances continue…. Eur J Med Chem 2014; 72: 52-77.
| Crossref | Google Scholar | PubMed |
4 Diurno M V, Izzo AA, Mazzoni O, Bolognese A, Capasso F. Antidiarrhoeal activity of new thiazolidinones related to loperamide. J Pharm Pharmacol 1996; 48(7): 760-2.
| Crossref | Google Scholar | PubMed |
5 Ergene N, Capan G. Synthesis and anticonvulsant activity of new 4-thiazolidone and 4-thiazoline derivatives. Farmaco 1994; 49(2): 133-5.
| Google Scholar | PubMed |
6 Chavan AA, Pai NR. Synthesis and antimicrobial screening of 5-arylidene-2-imino-4-thiazolidinones. Arkivoc 2007; 2007(16): 148-55.
| Crossref | Google Scholar |
7 Abeed AAO, Youssef MSK, Hegazy R. Synthesis, anti-diabetic and renoprotective activity of some new benzazole, thiazolidin-4-one and azetidin-2-one derivatives. J Braz Chem Soc 2017; 28(11): 2054-63.
| Crossref | Google Scholar |
8 Agrawal N, Upadhyay PK, Shah K, Mishra P. Antidiabetic activity of some synthesized 2- (substituted phenyl) -3-(naphthalen-1-yl)thiazolidin-4-ones. J Indian Chem Soc 2017; 94: 913-9.
| Google Scholar |
9 Diurno MV, Mazzoni O, Piscopo E, Calignano A, Giordano F, Bolognese A. Synthesis and antihistaminic activity of some thiazolidin-4-ones. J Med Chem 1992; 35(15): 2910-2.
| Crossref | Google Scholar | PubMed |
10 Gavade SN, Markad VL, Kodam KM, Shingare MS, Mane D V. Synthesis and biological evaluation of novel 2,4,6-triazine derivatives as antimicrobial agents. Bioorg Med Chem Lett 2012; 22(15): 5075-7.
| Crossref | Google Scholar | PubMed |
11 Türe A, Ergül M, Ergül M, Altun A, Küçükgüzel İ. Design, synthesis, and anticancer activity of novel 4-thiazolidinone-phenylaminopyrimidine hybrids. Mol Divers 2020; 25: 1025-50.
| Crossref | Google Scholar | PubMed |
12 Szychowski KA, Leja ML, Kaminskyy DV, Binduga UE, Pinyazhko OR, Lesyk RB, et al. Study of novel anticancer 4-thiazolidinone derivatives. Chem Biol Interact 2017; 262: 46-56.
| Crossref | Google Scholar | PubMed |
13 Senkardes S, Kucukguzel S. Recent progress on synthesis and anticancer activity of 4-thiazolidinone. Mini Rev Org Chem 2016; 13(5): 377-88.
| Crossref | Google Scholar |
14 Rawal RK, Prabhakar YS, Katti SB, De Clercq E. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Bioorganic Med Chem 2005; 13(24): 6771-6.
| Crossref | Google Scholar | PubMed |
15 Kato T, Ozaki T, Tamura K, Suzuki Y, Akima M, Ohi N. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 2. Structure-activity relationships of thiazolidinone derivatives. J Med Chem 1999; 42(16): 3134-46.
| Crossref | Google Scholar | PubMed |
16 Tanabe Y, Suzukamo G, Komuro Y, Imanishi N, Morooka S, Enomoto M, et al. Structure–activity relationship of optically active 2-(3-pyridyl)thiazolidin-4-ones as a PAF antagonists. Tetrahedron Lett 1991; 32(3): 379-82.
| Crossref | Google Scholar |
17 Kato T, Ozaki T, Ohi N. Improved synthetic methods of CP-060S, a novel cardioprotective drug. Tetrahedron Asymmetry 1999; 10(20): 3963-8.
| Crossref | Google Scholar |
18 Adachi Y, Suzuki Y, Homma N, Fukazawa M, Tamura K, Nishie I, et al. The anti-ischemic effects of CP-060S during pacing-induced ischemia in anesthetized dogs. Eur J Pharmacol 1999; 367(2–3): 267-73.
| Crossref | Google Scholar | PubMed |
19 Ottaná R, Mazzon E, Dugo L, Monforte F, Maccari R, Sautebin L, et al. Modeling and biological evaluation of 3,3′-(1,2-ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor. Eur J Pharmacol 2002; 448(1): 71-80.
| Crossref | Google Scholar | PubMed |
20 Yamamoto SH, Okumura H, Suzukamoc G. Synthetic study of the highly potent and selective anti-platelet activating factor thiazolidin-4-one agents and related compounds. J Chem Soc, Perkin Trans 1 1995; 1995(7): 935-47.
| Crossref | Google Scholar |
21 Kato Y, Kita Y, Nishio M, Hirasawa Y, Ito K, Yamanaka T, et al. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Eur J Pharmacol 1999; 384(2–3): 197-202.
| Crossref | Google Scholar | PubMed |
22 Voss ME, Carter PH, Tebben AJ, Scherle PA, Brown GD, Thompson LA, et al. Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-α antagonists. Bioorganic Med Chem Lett 2003; 13(3): 533-8.
| Crossref | Google Scholar | PubMed |
23 Hunter L. Fluorine chemistry. Aust J Chem 2015; 68(1): 3.
| Crossref | Google Scholar |
25 Kukhar VP, Sorochinsky AE, Soloshonok VA. Practical synthesis of fluorine-containing α- And β-amino acids: recipes from Kiev, Ukraine. Future Med Chem 2009; 1(5): 793-819.
| Crossref | Google Scholar | PubMed |
26 Kuznetsova L, Ungureanu IM, Pepe A, Zanardi I, Wu X, Ojima I. Trifluoromethyl- and difluoromethyl-β-lactams as useful building blocks for the synthesis of fluorinated amino acids, dipeptides, and fluoro-taxoids. J Fluor Chem 2004; 125(4): 487-500.
| Crossref | Google Scholar |
27 Maienfisch P, Hall RG. The importance of fluorine in the life science industry. Chimia 2004; 58(3): 93-9.
| Crossref | Google Scholar |
28 Ismail FMD. Important fluorinated drugs in experimental and clinical use. J Fluor Chem 2002; 118(1–2): 27-33.
| Crossref | Google Scholar |
29 Zhang C, Chu M. Leflunomide: A promising drug with good antitumor potential. Biochem Biophys Res Commun 2018; 496(2): 726-30.
| Crossref | Google Scholar | PubMed |
30 Ottanà R, MacCari R, Barreca ML, Bruno G, Rotondo A, Rossi A, et al. 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents. Bioorganic Med Chem 2005; 13(13): 4243-52.
| Crossref | Google Scholar | PubMed |
32 Gao M, Nettles RE, Belema M, Snyder LB, Nguyen VN, Fridell RA, et al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 2010; 465(7294): 96-100.
| Crossref | Google Scholar | PubMed |
33 Bolli MH, Abele S, Binkert C, Bravo R, Buchmann S, Bur D, et al. 2-Imino-thiazolidin-4-one derivatives as potent, orally active S1P 1 receptor agonists. J Med Chem 2010; 53(10): 4198-211.
| Crossref | Google Scholar | PubMed |
34 Malik S, Upadhyaya PK, Miglani S. Thiazolidinediones: a plethro of biological load. Int J PharmTech Res 2011; 3(1): 62-75.
| Google Scholar |
35 Appalanaidu K, Dadmal TL, Patil SM, Jagadeesh Babu N, Laxmikanth Rao J, Kumbhare RM. An efficient one-shot metal-free electrophilic fluorination of 2-iminothiazolidine-4-one. ChemistrySelect 2020; 5(20): 6054-8.
| Crossref | Google Scholar |
36 Коbylinska LI, Boiko NM, Panchuk RR, Grytsyna II, Klyuchivska OY, Biletska LP, et al. Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in rats. Croat Med J 2016; 57(2): 151-63.
| Crossref | Google Scholar | PubMed |
37 Kulabaş N, Özakpinar ÖB, Özsavcı D, Leyssen P, Neyts J, Küçükgüzel İ. Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anticancer and antiviral agents. Marmara Pharm J 2017; 21(2): 371-84.
| Crossref | Google Scholar |
38 Parameswari P, Devika R. In silico molecular docking studies of quercetin compound against anti-inflammatory and anticancer proteins. Res J Pharm Technol 2019; 12(11): 5305-9.
| Crossref | Google Scholar |
39 Shaty MH, Al-Ezzi MI, Arif IS, Basil D. Effect of metformin on inflammatory markers involved in cardiotoxicity induced by doxorubicin. Res J Pharm Technol 2019; 12(12): 5815-21.
| Crossref | Google Scholar |
40 Kadam SD, Mammen D, Kadam DS, Patil SG, Bagul RR, Doshi A, et al. Synthesis of novel fluorinated 5-benzylidine-3-ethyl-2-(2,3,4-trifluorophenylimino)thiazolidin-4-one derivatives using knoevenagel reaction and evaluation of their in vitro antimicrobial potentials. Asian J Chem 2023; 35(8): 1884-90.
| Crossref | Google Scholar |
41 Kadam SD, Mammen D, Kadam DS, Patil SG. In silico molecular docking against C-KIT tyrosine kinase and ADME studies of 3-ethyl-2-(2,3,4-trifluoro-phenylimino)-thiazolidin-4-one derivatives. Asian J Res Chem 2023; 16(1): 13-22.
| Crossref | Google Scholar |
42 Kadam DS, Patil GS, Mammen D, Kadam SD, More V. In silico molecular docking against c-KIT tyrosine kinase and ADME studies of 4-thiazolidinone derivatives. J Appl Organomet Chem 2023; 3(1): 13-27.
| Crossref | Google Scholar |
43 Tang SQ, Lee YYI, Packiaraj DS, Ho HK, Chai CLL. Systematic evaluation of the metabolism and toxicity of thiazolidinone and imidazolidinone heterocycles. Chem Res Toxicol 2015; 28(10): 2019-33.
| Crossref | Google Scholar | PubMed |
44 Keil AM, Frederick DM, Jacinto EY, Kennedy EL, Zauhar RJ, West NM, et al. Cytotoxicity of thiazolidinedione-, oxazolidinedione- and pyrrolidinedione-ring containing compounds in HepG2 cells. Toxicol Vitr 2015; 29(7): 1887-96.
| Crossref | Google Scholar | PubMed |
45 Revelant G, Huber-Villaume S, Dunand S, Kirsch G, Schohn H, Hesse S. Synthesis and biological evaluation of novel 2-heteroarylimino-1,3-thiazolidin-4-ones as potential anti-tumor agents. Eur J Med Chem 2015; 94: 102-12.
| Crossref | Google Scholar | PubMed |
46 George RF. Stereoselective synthesis and QSAR study of cytotoxic 2-(4-oxo-thiazolidin- 2-ylidene)-2-cyano-N-arylacetamides. Eur J Med Chem 2012; 47(1)): 377-86.
| Crossref | Google Scholar | PubMed |
47 Kadam D, Patil S, Kadam S, Doshi A, Patel F. Synthesis of novel fluorinated 5-benzylidine-3-ethyl-2-(2,3,4-trifluorophenylimino)thiazolidin-4-one derivatives using knoevenagel reaction and evaluation of their in vitro antimicrobial potentials. Asian J Chem 2022; 9(8): 691-8.
| Crossref | Google Scholar |
48 Yaping C, Hongmei L, Zeli Y, Gang W. Two new oxovanadium(IV) compounds containing amino acid schiff base and 1,10-bathophenanthroline ligands: syntheses, crystal structures, and in vitro evaluation of the anticancer activities. Aust J Chem 2017; 70: 608-13.
| Crossref | Google Scholar |
49 Nikhila G, Naveen P, Udayakumar D, Manjunatha K. Indole-3-carbinol and 1,3,4-oxadiazole hybrids: synthesis and study of anti-proliferative and anti-microbial activity. Aust J Chem 2015; 68: 1603-13.
| Crossref | Google Scholar |
50 El Malah T, Nour HF, Nayl AA, Elkhashab RA, Abdel-Megeid FME, Ali. MM. Anticancer evaluation of tris(triazolyl)triazine derivatives generated via Click chemistry. Aust J Chem 2016; 69: 905-10.
| Crossref | Google Scholar |
